NeuroBo Pharmaceuticals I... (NRBO)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -12.47M -13.97M -15.28M -29.68M -21.31M -23.64M -33.41M -14.59M -9.03M -320.00K
Depreciation & Amortization 6.00K 20.00K 48.00K 46.00K 17.00K 346.00K 137.00K -17.00K - -
Stock-Based Compensation 222.00K 854.00 662.00 699.00 118.00 4.13M 5.27M 1.72M 284.00K 53.00K
Other Working Capital 4.28M -966.00K 578.00K -314.00K 1.79M -770.00K -903.00K 441.00K 1.00M 23.00K
Other Non-Cash Items -2.95M 2.55M 24.00K 17.36M 12.28M 346.00K 137.00K 200.00K 1.87M 55.00K
Deferred Income Tax - - - - 1.11M -346.00K -137.00K -276.00K - -
Change in Working Capital 4.40M -1.17M -584.00K 809.00K 744.00K -2.75M 1.10M 1.92M 1.45M 17.00K
Operating Cash Flow -10.80M -11.71M -15.13M -10.76M -7.04M -21.91M -26.90M -11.04M -5.43M -195.00K
Capital Expenditures -50.00K - -3.00K -4.00K -214.00K -3.00K - - - -
Acquisitions - 8.00K -583 180.00K 1.52M - - - - -
Purchase of Investments - - - - - - - - - -
Sales Maturities Of Investments - - - - - - - - - -
Other Investing Acitivies - 8.00 -582.42K -107.00K -7.37M - - - - -
Investing Cash Flow -50.00K 8.00K -586.00K 69.00K -6.06M -3.00K - - - -
Debt Repayment - - - - - 500.00K 10.00M 5.15M 7.42M 509.00K
Common Stock Repurchased - - - - - - - - - -
Dividend Paid - - - - - - - - - -
Other Financial Acitivies -80.00K -3.57M -1.97M -642.00K 24.17M -8.40M -1.20M -3.97M 1.32M -
Financial Cash Flow -80.00K 28.68K 22.03M 6.86M 24.17M 22.39M 21.34M 31.46M 8.74M 509.00K
Net Cash Flow -10.93M 16.98M 6.30M -3.83M 11.08M 481.00K -5.56M 20.41M 3.30M 314.00K
Free Cash Flow -10.85M -11.71M -15.14M -10.77M -7.25M -21.91M -26.90M -11.04M -5.43M -195.00K